Galmed Pharmaceuticals Ltd. buy Wells Fargo & Company
Start price
26.02.26
/
50%
€6.40
Target price
26.02.27
€87.99
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 26.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Galmed Pharmaceuticals Ltd. | - |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | -0.411% |
| iShares Nikkei 225® | 1.838% |
| iShares S&P 500 | -0.712% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (GMED) had its price target raised by Wells Fargo & Company from $98.00 to $104.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
07.11.25
07.11.25
€68.47
07.11.26
07.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
08.08.25
08.08.25
€56.60
08.08.26
08.08.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
21.02.25
21.02.25
€88.72
21.02.26
21.02.26
-
22.02.26
22.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
11.12.24
11.12.24
€90.54
11.12.25
11.12.25
-
12.12.25
12.12.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€81.94
06.11.25
06.11.25
-
07.11.25
07.11.25